Abstract
Purpose
As the number of people living with and beyond cancer increases, connected health technologies offer promise to enhance access to care and support, while reducing costs. However, uptake of connected health technologies may vary depending on sociodemographic and health-related variables. This study aimed to investigate demographic and health predictors of connected health technology use among people living with and beyond cancer.
Methods
Cross-sectional data from the US Health Information National Trends Survey Version 5 Cycle 4 (H5c4) was used. Regression analysis was used to examine associations between sociodemographic factors and the use of connected health technologies. The sample was restricted to individuals who self-reported a cancer diagnosis or history of cancer.
Results
In this cycle, 626 respondents self-reported a cancer diagnosis, with 41.1% using connected health technologies (health and wellness apps and/or wearable devices). Most were female (58.9%) and white (82.5%); 43.4% had graduated college or higher education. One third (33.6%) had a household income of $75,000 or more. Respondents who were younger, have higher education, were living as married, had higher incomes, had higher self-rated health and had higher health-related self-efficacy were significantly more likely to use connected health technologies. There were no significant associations between gender, race, stratum, time since diagnosis, history of anxiety or depression, and use of connected health technologies among people living with and beyond cancer.
Conclusions
Connected health technology use among people living with and beyond cancer is associated with sociodemographic factors. Future research should examine these demographic disparities as the use of connected health technologies in healthcare continues to gather momentum.
Implications for cancer survivors
The study underscores a disparity in connected heath technology usage among people living with and beyond cancer. There is a pressing need for research into adoption barriers and interventions to ensure equitable digital healthcare integration among this population, especially with the heightened adoption of technology post COVID-19 pandemic.
Similar content being viewed by others
Avoid common mistakes on your manuscript.
Introduction
The number of people living with and beyond cancer (PLWBC) continues to increase globally due to improvements in early detection and treatment and the aging world population [1]. Cancer is now considered a long-term illness with roughly half of cancer patients surviving a period of 10 or more years [2]. Despite the improved cancer survival rates PLWBC have diverse unmet needs [3]. Many PLWBC experience chronic physical symptoms from treatment side effects [4, 5], psychological distress, fatigue, sleep problems, and decreased quality of life [6] and could benefit from ongoing care and support [7, 8].
The growing population of PLWBC requires expansion of healthcare services to meet their needs and to reduce access gaps [9, 10]. As technology continues to be integrated into both healthcare and society at large, digital technologies offer promising possibilities for organization and delivery of care and support [11]. Connected health technologies (CHT), an umbrella term that encompasses concepts of e-health, mhealth, telehealth, and wearables, among other technologies, differ from other technologies in that they offer a two-way flow of information that involves gathering, analysis and return of user data to provide insights to patients and health care professionals [12, 13]. CHT may be effective in supporting patient education, self-management and personalized support in PLWBC [14,15,16]. Additionally, CHT could reduce logistical barriers associated with in-person care and participation such as time and travel burden [11], making them especially useful in the cancer survivorship context [17, 18].
Adoption and usage of CHT have been widely examined across various patient populations [19, 20], with a growing body of research in the aftermath of the global COVID-19 pandemic [21,22,23]. These studies report mixed but promising findings on CHT uptake and efficiency [18, 23]. Studies conducted among people with cancer have reported variations in uptake and efficacy [17], indicating the need for further studies to examine predictors, preferences, and attitudes towards use and adoption. Moreover, a recent study examining technology usage over the course of a decade found that while the prevalence and adoption of digital health among cancer PLWBC has continued to rise, the digital divide remains prevalent in this population [24, 25]. The digital divide has been associated with health inequities, as differential access to or usage of CHT across various demographics may result in uneven health outcomes [24]. A recent review by Yao et al. (2022) found that CHT can foster health disparities based on individuals’ ability to adopt technology and their health outcomes, influenced by factors like age, race, location, economic status, education, health status, and eHealth literacy [26]. In their analysis of health disparities, Saeed and Masters (2021) posited that while technological advancements in healthcare aim to enhance outcomes, it is imperative to ensure equitable distribution of these outcomes across various demographics [27]. Moreover, the World Health Organization’s digital health strategy 2020–2025 underlines the importance of acknowledging and addressing demographic disparities when implementing CHT to ensure equitable health outcomes [28].
Despite significant evidence linking socioeconomic factors, access to technology, and digital literacy to technology usage and adoption [20, 29], there is limited research on these associations amidst the rapidly evolving technology landscape. In this study, we used the Health Information National Trends Survey (HINTS) Five, Cycle 4 data [30, 31] to investigate demographic and health-related variables associated with CHT use among PLWBC. The National Cancer Institute (NCI) has conducted HINTS every few years since 2003 to assess health-related information use among civilian, non-institutionalized adults aged 18 or older in the US. HINTS provides the NCI with a comprehensive assessment of the American public’s access to and use of information about cancer across the cancer care continuum from cancer prevention, early detection, diagnosis, treatment, and survivorship.
Materials and methods
Study design and procedures
This study used the 5th version of HINTS dataset (HINTS 5 Cycle 4; H5c4) which was collected solely by mail between February 2020 and June 2020. As with prior HINTS iterations, the sampling frame for Cycle 4 consisted of a database of addresses used by Marketing Systems Group to provide random samples of all non-vacant residential addresses in the United States. A two-stage stratified random sampling methodology was used. In the first stage, residential addresses across the United States were selected. In the second stage, one adult was selected within each sampled household. The full sampling and weighting process of H5c4 is described in the HINTS methodology report [31].
Participants
The total number of addresses selected for Cycle 4 was 15,350. Eligible data was obtained from 3865 respondents, of which 16.2% (n = 626) were PLWBC (i.e., respondents who answered “Yes” to the survey item “have you ever been diagnosed with cancer?”) [32]. Respondents who responded “no” to this question and those who did not respond to the question (or whose data were missing) were excluded from these analyses.
Measures
Sociodemographic information and disease history
Data were gathered on participants’ age, sex at birth, marital status, the highest level of education, household annual income, race/ethnicity, region/stratum, and years since diagnosis.
Use of connected health technologies
Use of connected health technologies (health or wellness apps and wearable devices) was determined based on an affirmative response to either of the following two questions “In the past 12 months, have you used any of these health or wellness apps?” and “In the last 12 months, have you used an electronic wearable device to monitor or track your health or activity? For example, a Fitbit, AppleWatch or Garmin Vivofit…” The first question was preceded by a question that required respondents to indicate if they had any “apps” related to health and wellness. We did not analyze this question as our focus was on active use of the “apps.”
Self-rated health
Self-rated health was measured using a single item on a five-point Likert scale (from 1 = excellent to 5 = poor). For purposes of analysis, we dichotomized responses by combining “excellent, very good and good” into one category and “fair and poor” into another category; combined categories were renamed “good” and “poor,” respectively.
Health-related self-efficacy
Health-related self-efficacy was measured using a single item asking respondents how confident they were in their ability to take good care of their health, on a five-point Likert scale (1 = completely confident to 5 = not confident at all). As with the self-rated health measure, for purposes of analysis, we reduced the five categories into a binary variable (confident/not confident) by combining “completely confident, very confident, somewhat confident” into one category and “a little confident and not confident at all” into another category.
History of depression or anxiety
Lifetime history of depression or anxiety was measured by the item “Has a doctor or other health professional ever told you that you had depression or anxiety disorder?” (yes/no).
Data analysis
The Statistical Package for Social Sciences (SPSS) was used for analysis. We restricted our present analysis to respondents who self-reported a cancer diagnosis. Descriptive statistics were used to examine the usage of CHT (health apps and wearable devices). Chi-squared tests and multivariable regression were conducted to assess associations between use of CHT and sociodemographic characteristics, and general health status, including the self-reported history of psychological disorders (anxiety and/or depression), self-rated health, and health related self-efficacy. Finally, multivariate logistic regression was conducted to identify predictors of CH usage. Statistical significance was set at p < 0.05.
Results
Sample characteristics
The sample characteristics are provided in Table 1. A total of 626 respondents reported to have ever been diagnosed with cancer. The majority were female (58.9%) and over the age of 65 (63.6%). Nearly half of the respondents were married (49%). Over two-thirds had completed at least some college education (71%), and approximately half had an annual household income above $50,000 (50.8%). Most identified as white (82.5%) and lived in high minority areas (57.2%). 48.4% were diagnosed with cancer 11 or more years ago. Almost three quarters of the PLWBC (74%) rated their general health as “good” and 69% “felt confident” in their ability to take care of their health. About a quarter of the respondents (24.4%) had been diagnosed with depression or anxiety.
Use of connected health technologies
Overall, 41.1% (n = 257) of the sample reported using health or wellness apps and/or wearable devices to manage the health and wellbeing in the past year (Table 2).
Association between demographic variables and CHT use
Table 3 shows associations between sociodemographic variables and CHT usage in the past year. Age, marital status, level of education, and household income were significantly associated with technology use at the bivariate level. PLWBC aged 18–64 years were more likely to use technology compared to those aged 65 and above (OR = 2.65, 95% CI = 1.89–3.72, p < 0.001). Those with a college degree or higher had higher odds of technology use compared to those with less than a high school education (OR = 10.69, 95% CI = 3.71–30.76, p < 0.001). Similarly, PLWBC with a household income of $75,000 or more had higher odds of technology use compared to those with an income of less than $20,000 (OR = 4.98, 95% CI = 2.93–8.47, p < 0.001). Additionally, PLWBC who rated their health as “good” were more likely to use CHT (OR = 2.39, 95% CI = 1.61–3.54, p < 0.001) compared to those who rated their health as “poor.” Similarly, respondents who reported being confident about their ability to take good care of their health were more likely to use CHT (OR = 1.50, 95% CI = 1.05–2.13, p < 0.001) compared to those who were less confident. Sex at birth, race, time since diagnosis, and lifetime diagnosis of depression/anxiety were not significantly associated with CHT use.
CHT use among PLWBC
In adjusted models, age, marital status, household income, and self-rated general health were significant, independent predictors of CHT usage. Specifically, those aged 18–64 years were significant more likely to use CHT (aOR = 2.06, 95% CI = 1.35–3.13, p = 0.001) than older adults. PLWBC with an income of $75,000 were more likely to use CHT (aOR = 3.10, 95% CI = 1.48–6.49, p = 0.003) compared to those with less than $20,000. Those who rated their general health as good were more likely to use CHT (aOR = 1.92, 95% CI = 1.09–3.38, p = 0.023) compared to those who rated their health as poor (see Table 4).
Discussion
This study investigated usage and sociodemographic predictors of a subset of CHT (health apps and wearable devices) among PLWBC using a nationally representative sample of United States adults. We found that nearly half of PLWBC used some the form of CHT; however, usage varied across sociodemographic and health-related variables. Our study found higher CHT usage in PLWBC compared to analysis of previous HINTS datasets [33, 34], suggesting that usage is increasing among this population. This underscores earlier findings on the potential of CHT, particularly emerging technologies such as health and wellness apps and wearable devices [15, 33], to offer new avenues for reaching PLWBC with targeted interventions.
Our findings suggest that CHT usage varies across various sociodemographic and health related variables. We found that younger individuals, with higher levels of education, higher income, and living as married were more likely to use CHT. These findings are consistent with prior studies which reported disparities in the use of CHTs in PLWBC [24]. This suggests that, although CHT usage and adoption is on the rise, a digital divide still persists and this could potentially worsen health disparities [27], implying that certain individuals may be “digitally disconnected” and therefore unable to use CHT for their heath needs [35, 36]. Furthermore, it is important to address these disparities in CHT usage to prevent exacerbation of existing health inequalities as was the case during the COVID-19 pandemic [37]. This may include working to improve access to and knowledge of these technologies among PLWBC with lower socioeconomic status, as well as ensuring that these technologies are designed in a way that is accessible and usable for all people impacted by cancer, whose population is on the rise, regardless of their socioeconomic status.
The finding that there was no association between a history of anxiety and depression and usage of CHT suggests that mental health history may not play a significant role in an individual's likelihood of using CHT. Although there is evidence suggesting that severe mental illness could be a barrier to technology usage [38], our findings are consistent with a previous study that found people with a history of depression and anxiety used CHT at similar rates to the general population.[39]. This suggests that mental health history may not be a barrier to CHT use for managing conditions such as cancer. Furthermore, it suggests that CHT may be a useful tool for individuals with a history of mental health conditions who are managing other health issues. However, it is also possible that the questions used in this survey were not sensitive enough to establish this association, and further research is needed to examine the association.
Our finding that PLWBC with higher self-rated health were more likely to use CHT is consistent with previous research [40, 41]. This suggests that technologies designed to enhance self-rated health and self-efficacy may be particularly effective in engaging PLWBC and promoting their use of these technologies. For instance, by providing features that enable individuals to track and manage their health, set goals, and receive feedback, these technologies may help foster a sense of control and confidence in managing their health. However, further research is needed to better understand the mechanisms through which these factors influence technology adoption and usage among PLWBC and to identify strategies for promoting the adoption and effective use.
Study limitations and strengths
There are several limitations to this study. Firstly, the cross-sectional nature of the data means that it can only provide information on associations of CHT usage rather than causal relationships. Secondly, there is the possibility of recall bias since the survey relied on self-reported information and required participants to recall past behaviors, such as their use of CHT in the past year. Third, the HINTS only examined a subset of CHT (health apps and wearable devices), and this is not inclusive of all CHT such as electronic health records, whose usage might be different. Additionally, due to the nature of questions used in the survey, we were unable to obtain specific information on the types, content, design, and characteristics of health apps, their frequency of use, number of apps, and costs. Finally, data collection in this HINTS cycle was impacted by COVID-19 mitigations which reduced the workforce available for distributing survey packets, leading to a modified mailing schedule with longer intervals between mailings and possible delays [31]. A strength of this study is that the responses in this iteration (H5c4) were collected through mail, thereby avoiding any bias that may arise from “using technology to study technology.” Secondly, the sample used for the study was nationally representative, enhancing the generalizability of the findings to the broader population.
Conclusion
While usage of CHT among PLWBC is on the rise, this study has shown that use varies across sociodemographic and health-related variables, with those who are older and with lower SES less likely to use CHT. To ensure that the expansion of CHT does not worsen existing healthcare disparities, future research should focus on addressing the barriers to usage and adoption and expanding their reach to all subgroups of PLWBC. Additionally, future studies should examine barriers and enablers to use of these technologies, considering the increasing digitalization of healthcare, particularly in the aftermath of COVID 19 pandemic. Finally, as more recent, and richer iterations of HINTS datasets become available, future analyses should include a broader spectrum of connected health technologies.
Data availability
This data is publicly available and downloadable from the HINTS website [31]. The data that support the findings for this study are openly available in HINTS Public Use Dataset available at https://hints.cancer.gov/data/download-data.aspx.
References
Sung H, Ferlay J, Siegel RL, Laversanne M, Soerjomataram I, Jemal A, et al. Global Cancer Statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin United States. 2021;71:209–49.
Allemani C, Matsuda T, Di Carlo V, Harewood R, Matz M, Nikšić M, et al. Global surveillance of trends in cancer survival 2000–14 (CONCORD-3): analysis of individual records for 37 513 025 patients diagnosed with one of 18 cancers from 322 population-based registries in 71 countries. Lancet (London, England). England; 2018;391:1023–75.
Schmidt ME, Goldschmidt S, Hermann S, Steindorf K. Late effects, long-term problems and unmet needs of cancer survivors. Int J Cancer [Internet]. John Wiley & Sons, Ltd; 2022;151:1280–90. https://doi.org/10.1002/ijc.34152.
Devlin EJ, Denson LA, Whitford HS. Cancer treatment side effects: a meta-analysis of the relationship between response expectancies and experience. J Pain Symptom Manage Elsevier. 2017;54:245–58.
National Academies of Sciences and Medicine E. Long-term survivorship care after cancer treatment: Proceedings of a workshop. National Academies Press; 2018.
Schmidt ME, Wiskemann J, Steindorf K. Quality of life, problems, and needs of disease-free breast cancer survivors 5 years after diagnosis. Qual Life Res Springer. 2018;27:2077–86.
Levin NJ, Zebrack B, Cole SW. Psychosocial issues for adolescent and young adult cancer patients in a global context: a forward-looking approach. Pediatr Blood Cancer. 2019;66:e27789 Wiley Online Library.
Shapiro CL. Cancer survivorship. N Engl J Med Mass Med Soc. 2018;379:2438–50.
Prager GW, Braga S, Bystricky B, Qvortrup C, Criscitiello C, Esin E, et al. Global cancer control: responding to the growing burden, rising costs and inequalities in access. ESMO Open. 2018;3:e000285 BMJ Publishing Group Limited.
Farmer P, Frenk J, Knaul FM, Shulman LN, Alleyne G, Armstrong L, et al. Expansion of cancer care and control in countries of low and middle income: a call to action. Lancet Elsevier. 2010;376:1186–93.
Fisch MJ, Chung AE, Accordino MK. Using technology to improve cancer care: social media, wearables, and electronic health records. Am Soc Clin Oncol Educ B [Internet]. Wolters Kluwer; 2016;200–8. https://doi.org/10.1200/EDBK_156682.
Pattichis CS, Panayides AS. Connected Health. Front Digit Health. 2019;1:1. https://doi.org/10.3389/fdgth.2019.00001.
Caulfield BM, Donnelly SC. What is connected health and why will it change your practice? QJM An Int J Med. Oxford University Press. 2013;106:703–7.
Lim JY, Kim Y, Yeo SM, Chae BJ, Yu J, Hwang JH. Feasibility and usability of a personalized mHealth app for self-management in the first year following breast cancer surgery. Health Inform J [Internet]. 2023;29:14604582231156476. https://doi.org/10.1177/14604582231156476. SAGE Publications Ltd.
Gitonga I, Desmond D, Duda N, Maguire R. Impact of connected health interventions on psychological wellbeing and quality of life in patients with cancer: a systematic review and meta-analysis. Psychooncology [Internet]. John Wiley & Sons, Ltd; 2022;n/a. Available from: https://doi.org/10.1002/pon.6019
Signorelli GR, Lehocki F, Fernández MM, O’Neill G, O’Connor D, Brennan L, et al. A research roadmap: connected health as an enabler of cancer patient support. J Med Internet Res. 2019;21:e14360 JMIR Publications Inc., Toronto, Canada.
Mikles SP, Griffin AC, Chung AE. Health information technology to support cancer survivorship care planning: a systematic review. J Am Med Inform Assoc England. 2021;28:2277–86.
Penedo FJ, Oswald LB, Kronenfeld JP, Garcia SF, Cella D, Yanez B. The increasing value of eHealth in the delivery of patient-centred cancer care. Lancet Oncol Elsevier. 2020;21:e240–51.
Sim I. Mobile devices and health. N Engl J Med Mass Med Soc. 2019;381:956–68.
Kemp E, Trigg J, Beatty L, Christensen C, Dhillon HM, Maeder A, et al. Health literacy, digital health literacy and the implementation of digital health technologies in cancer care: the need for a strategic approach. Heal Promot J Aust. 2021;32:104–14 Wiley Online Library.
Murthy S, Kamath P, Godinho MA, Gudi N, Jacob A, John O. Digital health innovations for non-communicable disease management during the COVID-19 pandemic: a rapid scoping review. Bmj Innovations. 2023;9(1).
Paterson C, Bacon R, Dwyer R, Morrison KS, Toohey K, O’Dea A, et al. The role of telehealth during the COVID-19 pandemic across the interdisciplinary cancer team: implications for practice. Semin Oncol Nurs. Elsevier; 2020;151090.
Golinelli D, Boetto E, Carullo G, Nuzzolese AG, Landini MP, Fantini MP. Adoption of digital technologies in health care during the COVID-19 pandemic: systematic review of early scientific literature. J Med Internet Res. 2020;22:e22280 Canada.
Fareed N, Swoboda CM, Jonnalagadda P, Huerta TR. Persistent digital divide in health-related internet use among cancer survivors: findings from the Health Information National Trends Survey, 2003–2018. J Cancer Surviv United States. 2021;15:87–98.
Delemere E, Maguire R. Caregivers of children feel confident about using the internet for health information. Heal Inf Libr J. 2023;40:54–69 Wiley Online Library.
Yao R, Zhang W, Evans R, Cao G, Rui T, Shen L. Inequities in health care services caused by the adoption of digital health technologies: scoping review. J Med Internet Res. 2022;24:e34144 Canada.
Saeed SA, Masters RM. Disparities in health care and the digital divide. Curr Psychiatry Rep. 2021;23:1–6.
WHO. Global strategy on digital health 2020–2025. Geneva; 2021.
Delemere E, Maguire R. Technology usage, eHealth literacy and attitude towards connected health in caregivers of paediatric cancer. In: 2021 IEEE International Symposium on Technology and Society (ISTAS). IEEE; 2021. p. 1–6.
Finney Rutten LJ, Blake KD, Skolnick VG, Davis T, Moser RP, Hesse BW. Data resource profile: the National Cancer Institute’s Health Information National Trends Survey (HINTS). Int J Epidemiol [Internet]. 2020;49:17–17j. https://doi.org/10.1093/ije/dyz083.
Institute NC. Health Information National Trends Survey 5 (HINTS 5) Cycle 4 Methodology Report [Internet]. Westat; 2020. Available from: https://hints.cancer.gov/data/methodology-reports.aspx
Jiang S, Liu PL. Digital divide and internet health information seeking among cancer survivors: a trend analysis from 2011 to 2017. Psychooncology [Internet]. John Wiley & Sons; 2020;29:61–7. Available from: https://login.jproxy.nuim.ie/login?url = https://search.ebscohost.com/login.aspx?direct = true&db = psyh&AN = 2019–72518–001&site = ehost-live
Onyeaka HK, Zambrano J, Longley RM, Celano CM, Naslund JA, Amonoo HL. Use of digital health tools for health promotion in cancer survivors. Psychooncology [Internet]. 2021;30:1302–10. https://doi.org/10.1002/pon.5677. John Wiley & Sons, Ltd.
Jiang Y, West BT, Barton DL, Harris MR. Acceptance and use of eHealth/mHealth applications for self-management among cancer survivors. Stud Health Technol Inform. 2017;245:131 NIH Public Access.
Torous J, Bucci S, Bell IH, Kessing LV, Faurholt-Jepsen M, Whelan P, et al. The growing field of digital psychiatry: current evidence and the future of apps, social media, chatbots, and virtual reality. World Psychiatry [Internet]. 2021;20:318–35. https://doi.org/10.1002/wps.20883. John Wiley & Sons, Ltd.
Meskó B, Drobni Z, Bényei É, Gergely B, Győrffy Z. Digital health is a cultural transformation of traditional healthcare. Mhealth. 2017;3:38. https://doi.org/10.21037/mhealth.2017.08.07.
Beaunoyer E, Dupéré S, Guitton MJ. COVID-19 and digital inequalities: Reciprocal impacts and mitigation strategies. Comput Human Behav. 2020;111:106424 Elsevier.
Abu Rahal Z, Vadas L, Manor I, Bloch B, Avital A. Use of information and communication technologies among individuals with and without serious mental illness. Psychiatry Res [Internet]. 2018;266:160–7. Available from: https://www.sciencedirect.com/science/article/pii/S016517811732348X
Onyeaka H, Firth J, Kessler RC, Lovell K, Torous J. Use of smartphones, mobile apps and wearables for health promotion by people with anxiety or depression: an analysis of a nationally representative survey data. Psychiatry Res. 2021;304:114120 Elsevier.
Figueiredo M, Caldeira C, Chen Y, Zheng K. Routine self-tracking of health: reasons, facilitating factors, and the potential impact on health management practices. AMIA: Annu Symp proceedings AMIA Symp. 2017;2017:706–14 United States.
van Bussel MJP, Odekerken-Schröder GJ, Ou C, Swart RR, Jacobs MJG. Analyzing the determinants to accept a virtual assistant and use cases among cancer patients: a mixed methods study. BMC Health Serv Res [Internet]. 2022;22:890. https://doi.org/10.1186/s12913-022-08189-7.
Acknowledgements
We thank the US National Cancer Institute for conducting HINTS and making it publicly available and downloadable for secondary analysis.
Funding
Open Access funding provided by the IReL Consortium. This publication has emanated from research supported in part by a grant from Science Foundation Ireland under Grant number 18/CRT/6222. For the purpose of Open Access, the author has applied a CC BY public copyright licence to any Author Accepted Manuscript version arising from this submission.
Author information
Authors and Affiliations
Contributions
IG, RM, and DD conceptualized the study. IG conducted the analysis and wrote the first draft. RM and DD reviewed and edited the draft. All authors read and approved the final manuscript.
Corresponding author
Ethics declarations
Ethics approval
Ethical approval for this secondary analysis was obtained from Maynooth University Research Ethics Committee (reference: SRESC-2022–2475301).
Conflict of interests
The authors have no conflicts of interest to declare.
Additional information
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/.
About this article
Cite this article
Gitonga, I., Desmond, D. & Maguire, R. Who uses connected health technologies after a cancer diagnosis? evidence from the US Health Information National Trends Survey. J Cancer Surviv (2024). https://doi.org/10.1007/s11764-024-01615-1
Received:
Accepted:
Published:
DOI: https://doi.org/10.1007/s11764-024-01615-1